National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Liver (Hepatocellular) Cancer Screening (PDQ®)
Patient Version   Health Professional Version   Last Modified: 02/15/2008



What is screening?






General Information About Liver (Hepatocellular) Cancer






Liver (Hepatocellular) Cancer Screening






Risks of Liver (Hepatocellular) Cancer Screening






Get More Information From NCI






Changes to This Summary (02/15/2008)






Questions or Comments About This Summary






About PDQ



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Risks of Liver (Hepatocellular) Cancer Screening

Key Points for This Section


Screening tests have risks.

Decisions about screening tests can be difficult. Not all screening tests are helpful and most have risks. Before having any screening test, you may want to discuss the test with your doctor. It is important to know the risks of the test and whether it has been proven to reduce the risk of dying from cancer.

The risks of liver cancer screening include the following:

False-negative test results can occur.

Screening test results may appear to be normal even though liver cancer is present. A person who receives a false-negative test result (one that shows there is no cancer when there really is) may delay seeking medical care even if there are symptoms.

False-positive test results can occur.

Screening test results may appear to be abnormal even though no cancer is present. A false-positive test result (one that shows there is cancer when there really isn't) can cause anxiety and is usually followed by diagnostic tests and procedures, such as a liver biopsy, which also have risks.

Side effects may be caused by procedures to diagnose liver cancer.

Abnormal screening results may lead to a liver biopsy to diagnose liver cancer. Liver biopsy may cause the following rare, but serious, side effects:

  • Hemorrhage.
  • Trouble breathing.
  • Leakage of bile, which can cause an infection of the lining of the abdomen.
  • A small puncture (hole) in an organ in the abdomen.
  • Spread of cancer cells along the needle path when the biopsy needle is inserted and withdrawn (taken out).

Your doctor can advise you about your risk for liver cancer and your need for screening tests.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov